2_ValGenesis JA 2266489.docx

Justification and Approval (J&A) at or Below the Simplified Acquisition Threshold

Project Title: ValGenesis Subscription Renewal

I. Identification of the agency and contracting activity

II. Description of the project, and supplies or services required to meet the agency’s needs A. Project Background

The Office of Cyber Infrastructure and Computational Biology (OCICB) provides leadership and direction on effective strategies, policies, and standards for technology services, support for biomedical research programs, information technology resources, and customer support. This includes ensuring information technology infrastructure, tools, and applications fully and comprehensively support the NIAID mission. The Clinical Informatics Branch within the OCICB provides specialized support to facilitate the integration of IT and clinical expertise to support NIAID’s research mission. The branch specializes in leveraging expertise to manage the implementation and configuration of industry standard research management tools. ValGenesis is digital validation software that aligns with industry standards for managing the computer system validation process for validating NIAID clinical systems.

B. Description of the supplies or services to be purchased

Quantity

Description

III. Identification of the statutory authority permitting other than full and open competition ☒ 41 USC 253(c)(1) and FAR Part 6.302-1: Only one responsible source

IV. Demonstration that the proposed contractor unique qualifications or the nature of the acquisition requires use of the authority cited.

A. Name and address of the proposed contractor

ValGenesis Inc 5201 Great America Parkway, Suite 354 Santa Clara, California 95054

B. Describe why only the requested supply/service will meet the government’s needs ValGenesis is critical to streamline and standardize validation activities to ensure compliance, data integrity, and operational efficiency for validating NIAID clinical systems. The ValGenesis Validation Lifecycle Management System (VLMS) aligns with industry standards for managing the computer systems validation process. This platform is designed to oversee the entire process, from validation, planning, and execution to reporting and maintenance. It’s used to streamline and standardize validation activities, ensuring compliance, data integrity, and operational efficiency. Additionally, it supports a lifecycle approach to managing validation processes, promoting consistency and enhancing adherence to policies and regulations. It provides an end-to-end digital validation platform, enabling 100% paperless, risk-based validation across areas such as CSV (Computer System Validation), CSA (Computerized System Assurance), CQV (Commissioning, Qualification, and Validation), and equipment validation.

ValGenesis supports human safety by ensuring rigorous compliance with regulatory standards and enhancing the reliability of validation processes by automating and digitizing the validation lifecycle to reduce the risk of human error and ensure all processes meet stringent quality requirements. By maintaining high standards of validation and compliance, ValGenesis plays a critical role ensuring software used throughout the product development and manufacturing processes meets regulatory guidelines thus safeguarding human health and safety. ValGenesis supports human healthcare by ensuring systems and processes used adhere to the highest standards of quality and compliance. The software provides the ability to manage the validation lifecycle, which helps to maintain the integrity and reliability of operations crucial for patient safety and effective treatment outcomes. The system's comprehensive validation management capabilities ensure that equipment, processes, and software used in healthcare settings are thoroughly tested and meet FDA and EMA regulatory requirements. This reduces the likelihood of errors and non-compliance that could compromise product quality or patient safety. Additionally, ValGenesis enhances operational efficiency and reduces validation cycle times, enabling faster delivery of safe and effective healthcare solutions to the market, ultimately supporting better patient care and health outcomes.

ValGenesis supports clinical research studies by providing a streamlined and compliant framework for managing the validation of systems and processes critical to clinical trials. Its digital platform automates the validation lifecycle, ensuring that all equipment, software, and methodologies used in clinical research meet rigorous regulatory standards, such as those set by the FDA and EMA. This automation reduces the risk of errors and non-compliance, which can compromise data integrity and patient safety. This tool is critical to support regulatory audit and inspection readiness. If ValGenesis is not renewed, there is potential for increased risk of non-compliance with regulatory standards due to the absence of centralized, automated validation processes. This could result in inefficient manual validation methods that are susceptible to human error, potentially leading to extended validation cycles. Without ValGenesis's real-time tracking, audit trails, and risk assessment features, the ability to swiftly identify and resolve validation issues may be compromised, affecting data integrity and product quality.

C. Describe why only the proposed contractor is capable of providing the requested supply/service

ValGenesis was established in 2005 and is the pioneer of digital validation and the inventor of the ValGenesis Validation Lifecycle Management System (VLMS), the industry’s first proven, 100% paperless end-to-end validation lifecycle management system. ValGenesis does not have any resellers/distributorships or service providers for their software.